Correlation Between Spyre Therapeutics and Mountain Crest
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Mountain Crest at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Mountain Crest into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and Mountain Crest Acquisition, you can compare the effects of market volatilities on Spyre Therapeutics and Mountain Crest and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Mountain Crest. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Mountain Crest.
Diversification Opportunities for Spyre Therapeutics and Mountain Crest
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Spyre and Mountain is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Mountain Crest Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mountain Crest Acqui and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Mountain Crest. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mountain Crest Acqui has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Mountain Crest go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and Mountain Crest
Given the investment horizon of 90 days Spyre Therapeutics is expected to generate 0.59 times more return on investment than Mountain Crest. However, Spyre Therapeutics is 1.69 times less risky than Mountain Crest. It trades about 0.01 of its potential returns per unit of risk. Mountain Crest Acquisition is currently generating about -0.28 per unit of risk. If you would invest 2,543 in Spyre Therapeutics on September 15, 2024 and sell it today you would lose (151.00) from holding Spyre Therapeutics or give up 5.94% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 15.08% |
Values | Daily Returns |
Spyre Therapeutics vs. Mountain Crest Acquisition
Performance |
Timeline |
Spyre Therapeutics |
Mountain Crest Acqui |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Spyre Therapeutics and Mountain Crest Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Spyre Therapeutics and Mountain Crest
The main advantage of trading using opposite Spyre Therapeutics and Mountain Crest positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Mountain Crest can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mountain Crest will offset losses from the drop in Mountain Crest's long position.Spyre Therapeutics vs. Puma Biotechnology | Spyre Therapeutics vs. Iovance Biotherapeutics | Spyre Therapeutics vs. Day One Biopharmaceuticals | Spyre Therapeutics vs. Inozyme Pharma |
Mountain Crest vs. Lipocine | Mountain Crest vs. Spyre Therapeutics | Mountain Crest vs. Tarsus Pharmaceuticals | Mountain Crest vs. Comstock Holding Companies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |